• BKT140 (BL-8040) CXCR4 Antagonist: Applied Oncology Workflow

  2026-07-07

  BKT140 (BL-8040) redefines precision in CXCR4-targeted oncology research by combining robust tumor migration inhibition with stem cell mobilization in a single, highly soluble compound. This article delivers actionable protocols, workflow enhancements, and troubleshooting strategies to help researchers maximize reproducibility and translational impact.

• CGF Induces ROS-Mediated Cell Cycle Arrest in Colorectal Can

  2026-07-07

  Jiang et al. reveal that the natural anthocyanin derivative CGF, extracted from purple sweet potato, suppresses colorectal cancer by inducing ROS-driven metabolic stress, mitochondrial dysfunction, and apoptosis. The study highlights a novel mechanism involving disruption of ABC transporters, ATP accumulation, MAPK/ERK/c-MYC axis suppression, and cell cycle arrest, with implications for targeted CRC therapy and advanced cell cycle analysis.

• Troxerutin Suppresses TRPM7-Mediated Mitochondrial Fission i

  2026-07-06

  This study elucidates how troxerutin mitigates diabetic cognitive dysfunction (DCD) by inhibiting mitochondrial fission through the TRPM7/calcineurin/Drp1ser637 axis. The findings clarify a mechanistic link between calcium overload and neuronal mitochondrial dynamics, suggesting new intervention targets for diabetes-related cognitive decline.

• CRISPR-Based Platform for Small Molecule Target Identificati

  2026-07-06

  This study presents a novel CRISPR knockout-based screening platform enabling efficient deconvolution of cellular targets of small-molecule activators of signaling pathways. By coupling a suicide gene to pathway activation and leveraging genome-wide CRISPR libraries, the platform provides a generalizable, unbiased method for identifying drug targets—demonstrated by uncovering STING as the target of the IFN-I activator BDW568.

• BOP Reagent: Pioneering Precision in Supramolecular Prodrug

  2026-07-05

  Explore how BOP reagent drives advanced peptide synthesis and phenyl ester preparation for next-generation carrier-free prodrug strategies. This article provides deep mechanistic insights and actionable guidance for leveraging BOP reagent in targeted chemotherapeutic design.

• Amplex Red (C4839): Reliable ROS Detection in Biomedicine

  2026-07-04

  This article explores how Amplex Red (SKU C4839) delivers reproducible, ultrasensitive detection of hydrogen peroxide and peroxidase activity in cell viability and redox assays. Drawing on peer-reviewed evidence and practical laboratory scenarios, it guides biomedical researchers in selecting and optimizing Amplex Red-based protocols for high-confidence oxidative stress monitoring.

• α-Amanitin: Mechanism, Evidence, and Protocols for RNA Polym

  2026-07-03

  α-Amanitin is a potent, specific inhibitor of eukaryotic RNA polymerase II, widely used in transcriptional regulation research. Its precise mechanism and robust benchmarks make it central to gene expression pathway analysis and developmental biology studies.

• GSH and GSSG Assay Kit: Precision Tools for Redox State Anal

  2026-07-03

  The GSH and GSSG Assay Kit enables simultaneous, quantitative detection of reduced and oxidized glutathione in diverse biological matrices. Its robust workflow and sensitivity make it indispensable for oxidative stress research, especially in tumor immunometabolism studies where reliable redox profiling is essential.

• Recombinant Human IL-15: Optimizing Immune Assays & Applicat

  2026-07-02

  Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized) empowers researchers to drive robust T and NK cell proliferation, bridging classic immune workflows with emerging neuroimmune models. This guide demystifies advanced protocol parameters, troubleshooting strategies, and cross-domain applications, leveraging the latest reference findings for translational impact.

• BAPTA Calcium Chelator: Advancing Calcium Signaling Modulati

  2026-07-02

  BAPTA enables precise control of intracellular calcium, revolutionizing cell signaling and apoptosis research, particularly in complex co-exposure models. Recent studies highlight its unmatched selectivity and reliability for dissecting environmental toxicant mechanisms.

• VX-745: Selective p38α MAPK Inhibitor for Inflammation Resea

  2026-07-01

  VX-745 is a highly selective p38α MAPK inhibitor with nanomolar potency. It blocks pro-inflammatory signaling and offers dual-action kinase inhibition, with demonstrated efficacy in multiple preclinical models. This article outlines the biological rationale, mechanism, and protocol parameters for research use.

• RSV NS3 Orchestrates Host Kinase Signaling for Pathogenicity

  2026-07-01

  Zhuang et al. (2025) reveal that Rice stripe virus (RSV) NS3 protein uses phosphorylation-dependent interactions with host kinases to precisely modulate viral pathogenicity and transmission. This mechanistic insight into virus-host-vector co-survival offers new directions for plant pathology and translational research.

• JNK-IN-7: Selective JNK Inhibitor for Apoptosis and Inflamma

  2026-06-30

  JNK-IN-7’s nanomolar potency and covalent selectivity enable precise dissection of apoptosis and innate immune signaling in cell models. This article bridges recent mechanistic breakthroughs with actionable assay workflows, troubleshooting, and comparative context for researchers targeting MAPK pathways.

• Oral mSWI/SNF PROTACs and Zosuquidar in Overcoming MDR in CR

  2026-06-30

  This study introduces AU-24118, an orally bioavailable mSWI/SNF ATPase dual degrader, demonstrating robust efficacy in castration-resistant prostate cancer (CRPC) models. Critically, the research uncovers ABCB1-mediated multidrug resistance—reversible by the P-glycoprotein inhibitor Zosuquidar (LY335979)—and defines strategies to overcome resistance in PROTAC-based cancer therapy.

• Z-VAD-FMK in Apoptosis Inhibition: Protocols, Use-Cases & In

  2026-06-29

  Z-VAD-FMK stands out as a gold-standard pan-caspase inhibitor, uniquely enabling precise dissection of apoptotic pathways in advanced cell biology models. This article translates cutting-edge research and workflow refinements into actionable, troubleshooting-driven guidance for leveraging Z-VAD-FMK in both routine and high-complexity apoptosis studies.

450 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page